Sonnet Biotherapeutics Holdings Inc
Biotechnology
Healthcare
SONN
3.92 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
5.92
52 week high
9.77
high
6.50
52 week low
0.00
low
5.60
growth
-25.50 %
previous Close
5.72
P/E ratio
market cap
23.55 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
-6.74 %
eps surprise
-93.88 %
net profit margin
0.00 %
0.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top